PATENT CLAIM ANALYSIS

Application Number: 15870306
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of an ANGPTL3 mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for reducing plasma lipids, plasma glucose and atherosclerotic plaques in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate any one or more of cardiovascular disease or metabolic disease, or a symptom thereof.

Claim (Index 12):
The method of  claim 11 , wherein the modified oligonucleotide consists of 20 linked nucleosides.

Metadata:
- Claim Count in Document: 61.0
- Percentile: 86.0
- Lexical Diversity: 1.86047
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14149715', '13520997', '14959714', '14701999', '14552436']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8147757849156145
- 35 USC 102 Novelty (BERT): 0.6075966345710083
- Combined Prediction Score: 0.7940578698811539
- Mean Citation Score: 453.858652
- Max Citation Score: 537.817
- Similarity Product: 500.9981509963871

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test